Migraine Headaches: More Than "Just a Headache" — What Your Doctor Wants You to Know About Diagnosis, Treatment, and Prevention in 2026

Roughly 39 million Americans live with migraine — a neurological condition that causes far more than a bad headache. According to CDC data, about 15 percent of U.S. adults experience migraine, and the condition disproportionately affects women, who are three times more likely to suffer from it than men. Despite being one of the most common reasons people visit a primary care doctor, migraine remains widely misunderstood, frequently self-treated, and too often dismissed as something you just push through. The reality is that migraine is a diagnosable, treatable medical condition — and the treatment landscape in 2026 is more effective and more accessible than it has ever been.

What Migraine Actually Is — and Why It's Not "Just a Headache"

Migraine is a neurological disorder, not simply a severe headache. It involves abnormal brain activity that affects nerve signaling, blood vessels, and the chemicals in your brain — most notably a protein called calcitonin gene-related peptide (CGRP), which plays a central role in migraine pain and inflammation.

A migraine attack can last anywhere from 4 to 72 hours untreated, and it typically involves a combination of symptoms that go well beyond head pain:

Not every migraine includes aura. In fact, migraine without aura is the most common form. Many people also experience a "prodrome" phase hours or even a day before the headache starts — subtle warning signs like food cravings, mood changes, neck stiffness, or excessive yawning. Recognizing these early signals can help you treat an attack before it peaks.

How Doctors Diagnose Migraine

One of the biggest misconceptions about migraine is that you need a brain scan to confirm it. In the vast majority of cases, migraine is diagnosed clinically — meaning your doctor can diagnose it based on your symptoms and medical history, without imaging.

The International Classification of Headache Disorders (ICHD-3) defines migraine without aura as at least five attacks meeting these criteria: headache lasting 4 to 72 hours, with at least two of four characteristics (one-sided location, pulsating quality, moderate-to-severe intensity, or worsening with routine physical activity), plus at least one associated symptom like nausea or sensitivity to light and sound.

In primary care, doctors often use the POUND mnemonic to quickly screen for migraine:

If you meet four or five of these criteria, the probability of migraine is high. This is a conversation your doctor can have with you over a telehealth visit — no imaging required in most cases.

Brain imaging (CT or MRI) is reserved for situations where your doctor suspects something other than migraine — for example, a sudden "worst headache of your life," headaches that change dramatically in character, new headaches after age 50, or headaches accompanied by neurological symptoms like weakness, numbness, or seizures.

Migraine Triggers: What Sets Off an Attack

Understanding your personal triggers is one of the most powerful tools in migraine management. Common triggers include:

A headache diary — even a simple note on your phone tracking when attacks occur, what you ate, how you slept, and what was happening — can reveal patterns your doctor can use to build a more targeted treatment plan.

How Migraine Is Treated: Acute Therapy

Acute treatment is what you take when a migraine attack is happening, with the goal of stopping it as quickly as possible. The current evidence, including the April 2025 guidance from the American Academy of Family Physicians (AAFP), supports a severity-based approach.

For mild to moderate attacks, over-the-counter options are first-line:

For moderate to severe attacks, prescription medications are usually needed:

Triptans remain the most effective class of acute migraine medication. A 2024 systematic review of 137 randomized controlled trials found that eletriptan, rizatriptan, sumatriptan, and zolmitriptan were the most effective triptans for pain relief. Triptans work by constricting blood vessels and blocking pain pathways in the brain. They are generally well tolerated, though they should be avoided in patients with uncontrolled hypertension, coronary artery disease, or a history of stroke.

Gepants (CGRP receptor antagonists) are a newer class that can treat acute migraine without the vascular risks of triptans. Ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) are FDA-approved options. Zavegepant (Zavzpret) is available as a nasal spray. These are particularly useful for patients who cannot take triptans due to cardiovascular concerns.

Anti-nausea medications like metoclopramide or ondansetron can be helpful alongside pain treatment, especially when nausea is a prominent symptom.

What to avoid: The 2025 ACP guidelines and AAFP guidance both recommend against using opioids or butalbital-containing medications (like Fioricet) for migraine unless all other options have failed. These medications carry significant risks of dependence and can worsen headaches over time through a phenomenon called medication-overuse headache.

Medication-Overuse Headache: The Trap Many Migraine Patients Fall Into

This is one of the most important — and least discussed — aspects of migraine care. When acute migraine medications are used too frequently, they can paradoxically cause more headaches. This is called medication-overuse headache (MOH), and it affects a significant number of chronic migraine patients.

The thresholds are clearer than many people realize. Using simple analgesics or NSAIDs on 15 or more days per month, or using triptans, opioids, or combination analgesics on 10 or more days per month, for three or more months, meets the diagnostic criteria for MOH.

The treatment is straightforward in concept but difficult in practice: reducing or stopping the overused medication, usually with the support of a preventive migraine medication to bridge the gap. This is exactly the kind of nuanced management that benefits from an ongoing relationship with a doctor who knows your history — not a one-off urgent care visit.

Migraine Prevention: When It's Time to Go Beyond Treating Attacks

If you're experiencing four or more migraine days per month, if your attacks are severe or prolonged, or if acute treatments aren't providing adequate relief, your doctor will likely recommend a preventive medication — a daily or monthly treatment designed to reduce the frequency and severity of attacks.

The February 2025 American College of Physicians (ACP) guideline on migraine prevention provides a clear, evidence-based framework:

First-line preventive options include medications that have been used for decades with strong evidence and low cost:

Second-line preventive options — recommended when first-line treatments are not tolerated or do not provide adequate relief — include the newer CGRP-targeting therapies:

These CGRP-targeted medications represent one of the most significant advances in migraine medicine in decades. They were designed specifically for migraine — unlike older preventives, which were borrowed from other conditions. The American Headache Society supports their use as a first-line option alongside traditional preventives, particularly for patients who prefer fewer side effects or who have comorbid conditions that make older medications less suitable.

Third-line: topiramate, an antiseizure medication, is recommended if prior options fail — though its side effect profile (cognitive dulling, weight loss, kidney stones) makes it less favored as a starting point.

The important clinical insight here: preventive treatment is not a last resort. If migraine is significantly affecting your work, relationships, or quality of life, starting a preventive medication early can change the trajectory of the disease and reduce the risk of progression to chronic migraine.

Migraine and Your Life: The Hidden Burden

Migraine does not just cause headaches. It causes missed workdays, canceled plans, strained relationships, and a persistent undercurrent of anxiety about when the next attack will strike. The U.S. economy loses an estimated $36 billion annually to migraine-related disability, and more than 4 million Americans visited an emergency department for head pain in 2022 alone.

Many people with migraine cycle through years of self-treatment — buying OTC medications in bulk, avoiding triggers as best they can, and white-knuckling through attacks — before ever discussing their headaches with a doctor. This is especially true for people without easy access to healthcare, people without insurance, or people who have been told in the past that migraines are "just something you deal with."

They are not. Migraine is a medical condition with medical treatments, and most of those treatments can be prescribed and managed through a primary care visit.

When to See Your Doctor

You should talk to a doctor about your headaches if:

At Trinity Family Medicine, we evaluate and treat migraine via secure telehealth visits across the entire state of Texas* — starting at just $49.99. You'll see the same board-certified physician every visit, which matters in migraine care because understanding your pattern, triggers, and treatment history is essential for getting your regimen right. No insurance is required, and appointments can often be scheduled same-day.

The Bottom Line

Migraine is not a character flaw, a stress problem, or something you should just tough out. It is a neurological condition with well-understood mechanisms, clear diagnostic criteria, and a growing arsenal of effective treatments — from time-tested generic triptans to precision-targeted CGRP therapies. If you are living with migraine and have never discussed it with a doctor, or if your current approach is not working, 2026 is an excellent time to revisit the conversation. The science has moved forward. Your treatment plan should, too.

References

Frequently Asked Questions About Migraine